RxDoctor Payments Data

Anh Mai, MD

Pediatrics · New Orleans, LANPI 1871913848

Payments from drug & device makers

$852in general payments, 2019–2025

Across 15 payments — averaging $56.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$465
  • Novo Nordisk$162
  • Coopersurgical, Inc.$90
  • Merz North America, Inc.$30
  • Argenx US, Inc.$22
  • Inari Medical, Inc.$20
  • plus $64 from 4 others

What the payments were for

  • Travel & lodging$46555%
  • Food & beverage$35842%
  • Gifts$304%

General payments by program year

20
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$852 in reported general payments places this provider in the 70th percentile of 913 pediatrics providers in Louisiana.

See all pediatrics providers in Louisiana

Medicare billing

Part B allowed, 2024
$14,088
Medicare patients
66
Services billed
206

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide37$39,191
JardianceEmpagliflozin17$19,966
TradjentaLinagliptin18$16,109
Repatha SureclickEvolocumab18$15,369
FarxigaDapagliflozin Propanediol12$9,111
EliquisApixaban11$8,573
Breo ElliptaFluticasone/Vilanterol19$7,088
Atorvastatin Calcium193$1,501
Albuterol Sulfate HfaAlbuterol Sulfate48$1,363
Diclofenac Sodium25$1,249
Levothyroxine Sodium88$848
Chlorthalidone52$840
Gabapentin59$781
Azelastine Hcl12$720
Losartan Potassium134$713

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$162$39,19137 claims
PfizerEliquis$16$8,57311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 913 pediatrics providers in Louisiana.

Other pediatrics in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →